Zobrazeno 1 - 10
of 89
pro vyhledávání: '"Peter E Lonergan"'
Autor:
Fidelma Fitzpatrick, Peter E Lonergan, Sanjith Gnanappiragasam, Elaine J Redmond, Deborah A McNamara
Publikováno v:
BMJ Open Quality, Vol 8, Iss 3 (2019)
Letters between hospital clinicians and general practitioners following an outpatient clinic (OPD) consultation have generally not been shared with patients. Recent guidelines from the Academy of Medical Royal Colleges recommend that all OPD letters
Externí odkaz:
https://doaj.org/article/378436a8e25b41f294d88bbc04add903
Publikováno v:
Nature Reviews Urology. 19:708-726
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9e94cfb7248ba2dda36deda4a91d01a
https://doi.org/10.1038/s41585-022-00649-3
https://doi.org/10.1038/s41585-022-00649-3
Autor:
Peter E. Lonergan, Avi Baskin, Scott A. Greenberg, Osama Mohamad, Samuel L. Washington, Shoujun Zhao, Janet E. Cowan, Jeanette M. Broering, Hao G. Nguyen, Matthew R. Cooperberg, Benjamin N. Breyer, Peter R. Carroll
Publikováno v:
Urology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1547434333d0cb8fa9238066684def16
https://doi.org/10.1016/j.urology.2023.05.012
https://doi.org/10.1016/j.urology.2023.05.012
Publikováno v:
Journal of Urology. 209
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a866e2bfad098a164e68e861cdfabd8e
https://doi.org/10.1097/ju.0000000000003346.04
https://doi.org/10.1097/ju.0000000000003346.04
Autor:
Shoujun Zhao, Matthew R. Cooperberg, Samuel L. WashingtonIII, Peter R. Carroll, Peter E. Lonergan, Janet E. Cowan, Jeanette M. Broering
Publikováno v:
Journal of Urology. 207:832-840
The association between androgen deprivation therapy (ADT) and dementia in men with prostate cancer remains inconclusive. We assessed the association between cumulative ADT exposure and the onset of dementia in a nationwide longitudinal registry of m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a5688acf22c361823a4b1a8a15d4f51
https://doi.org/10.1097/ju.0000000000002335
https://doi.org/10.1097/ju.0000000000002335
Autor:
Scott A. Greenberg, Janet E. Cowan, Peter E. Lonergan, Samuel L. Washington, Hao G. Nguyen, Ronald J. Zagoria, Peter R. Carroll
Publikováno v:
Prostate Cancer and Prostatic Diseases. 25:344-350
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc943289f88c1d68340275dd29c2ce2e
https://doi.org/10.1038/s41391-022-00527-4
https://doi.org/10.1038/s41391-022-00527-4
Autor:
Julie A. Szymaniak, Samuel L. Washington, Janet E. Cowan, Matthew R. Cooperberg, Peter E. Lonergan, Hao G. Nguyen, Maxwell V. Meng, Peter R. Carroll
Publikováno v:
Prostate Cancer and Prostatic Diseases.
Introduction Men with a detectable PSA after radical prostatectomy (RP) are often offered salvage therapy while those with an undetectable PSA are monitored. We aim to better characterize the natural history of men with an initially undetectable PSA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f1f145d769b9dcdbac1d64a93a20898
https://doi.org/10.1038/s41391-022-00638-y
https://doi.org/10.1038/s41391-022-00638-y
Autor:
Jang Hee Han, Annika Herlemann, Samuel L. Washington, Peter E. Lonergan, Peter R. Carroll, Matthew R. Cooperberg, Chang Wook Jeong
Publikováno v:
The World Journal of Men's Health. 41
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a10f720975ba5b0dc3c97411fe0925c
https://doi.org/10.5534/wjmh.220151
https://doi.org/10.5534/wjmh.220151
Autor:
Peter E. Lonergan
Publikováno v:
Urology Practice. 10:215-216
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a8aab9bc3f0d31fa32831dcd0ef69063
https://doi.org/10.1097/upj.0000000000000389.01
https://doi.org/10.1097/upj.0000000000000389.01
Autor:
Annika Herlemann, Peter R. Carroll, Scarlett Lin Gomez, Chang Wook Jeong, Matthew R. Cooperberg, Samuel L. Washington, Peter E. Lonergan
Publikováno v:
Prostate Cancer and Prostatic Diseases. 25:690-693
Background Active surveillance (AS) is generally recognized as the preferred option for men with low-risk prostate cancer. Current guidelines use prostate-specific antigen (PSA) of 10–20 ng/mL or low-volume biopsy Gleason grade group (GG) 2 as feat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d81c45ada571489fdfb67ee0440821a0
https://doi.org/10.1038/s41391-021-00448-8
https://doi.org/10.1038/s41391-021-00448-8